Drug profile · INN
pitolisant
OZAWADE
pitolisant (OZAWADE) is a histamine h3 receptor inverse agonist. Route of administration: film coated. Current US regulatory status: approved.
Drug details — pitolisant
- US status
- approved
- Class
- Nervous system (N07)
- Route
- FILM COATED
- Patents
- 3
- Programs
- 11
- Data quality
- 0.84
Quick answer
pitolisant (OZAWADE) is a histamine h3 receptor inverse agonist. Route of administration: film coated. Current US regulatory status: approved.
Key facts
Mechanism of action
Histamine H3 receptor inverse agonist
Primary target: Histamine H3 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is pitolisant?
pitolisant (OZAWADE) is a histamine h3 receptor inverse agonist. Route of administration: film coated. Current US regulatory status: approved.
What is the brand name for pitolisant?
OZAWADE is a marketed brand name for pitolisant. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pitolisant?
pitolisant has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.